Akt Expression and Prostate Cancer Outcomes
Author Information
Author(s): Le Page C, Koumakpayi I H, Alam-Fahmy M, Mes-Masson A-M, Saad F
Primary Institution: Centre de recherche du Centre Hospitalier de l’Université de Montréal
Hypothesis
The expression and localization of Akt-1, Akt-2, and Akt-3 correlate with clinical outcomes in prostate cancer patients.
Conclusion
Higher cytoplasmic expression of Akt-1 and Akt-2 is associated with a greater risk of PSA recurrence, while nuclear Akt-1 is linked to a lower risk of recurrence.
Supporting Evidence
- More than 60% of cancerous tissues overexpressed Akt-1, Akt-2, or Akt-3.
- Cytoplasmic Akt-1 expression correlated with a higher risk of postoperative PSA recurrence.
- Nuclear Akt-1 was significantly associated with a lower risk of PSA recurrence.
- Multivariate analysis identified clinical stage, Gleason score, and combined Akt markers as significant prognostic factors.
Takeaway
This study found that different forms of a protein called Akt behave differently in prostate cancer, with some forms linked to worse outcomes and others to better outcomes.
Methodology
The study analyzed the expression of Akt isoforms in prostate cancer tissues using immunohistochemistry on tissue arrays from 63 patients.
Potential Biases
Potential bias due to the retrospective nature of the study and the selection of tissue samples.
Limitations
The study is retrospective and may not account for all variables affecting patient outcomes.
Participant Demographics
Patients were primarily male with a median age of 62 years, and included various stages of prostate cancer.
Statistical Information
P-Value
0.046 for Akt-1 and 0.02 for Akt-2 regarding PSA recurrence.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website